NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-276-2005-0-US-04 Novel Small Molecule Inhibitors Of Botulinum Neurotoxin Metalloprotease Activity US DIV 12/487,761 Abandoned
NIAID E-019-2018-0-US-01 Complete Sequence Of The Genome Of Avian Parayxovirus Type 2 US 61/218,851 Abandoned
NIA E-205-2006-2-BR-03 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure BR National Stage PI0716495-5 Abandoned
NINDS E-011-2009-1-US-01 Methods For Regulating Cell Mitosis By Inhibiting Serine/Threonine Phosphatase US 61/269,101 Abandoned
NIAID E-232-2004-3-US-06 Compositions And Methods For Generating An Immune Response/04 US DIV 12/487,379 Abandoned
NIDCR E-003-1999-0-JP-21 Nucleic Acids Encoding a G-protein Coupled Receptor Involved in Taste Transduction. JP DIV 2009-144772 Expired
NIDCR E-003-1999-0-JP-20 Nucleic Acids Encoding a G-protein Coupled Receptor Involved in Taste Transduction. JP DIV 2009-144758 Abandoned
NCI E-148-1998-0-BE-18 Molecular Clones With Mutated HIV GAG/POL and SIV GAG Genes BE EP 09010047.0 Expired
NCI E-148-1998-0-NL-26 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes NL EP 09010047.0 Expired
NCI E-148-1998-0-FR-22 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes FR EP 09010047.0 Expired
NCI E-148-1998-0-DE-20 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes DE EP 09010047.0 Expired
NCI E-148-1998-0-GB-23 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes GB EP 09010047.0 Expired
NCI E-148-1998-0-CH-19 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes CH EP 09010047.0 Expired
NCI E-148-1998-0-ES-21 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes ES EP 09010047.0 Expired
NCI E-148-1998-0-IE-24 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes IE EP 09010047.0 Expired
NCI E-148-1998-0-IT-25 Molecular Clones With Mutated HIV GAG/POL, SIV GAG & SIV ENV Genes IT EP 09010047.0 Expired
NICHD E-214-2009-0-US-01 Stabilization Of Complexes For GeI Mobility Shift, Chromatography, And Capillary Electrophoresis US ORD 12/485,481 Abandoned
NCI E-282-2000-0-JP-09 Analogs of Thalidomide as Potential Angiogenesis Inhibitors JP DIV 2009-143087 Abandoned
NCI E-059-2009-0-US-01 RNA Nanoparticles and Methods of Use US 61/187,495 Abandoned
NCI E-137-2003-1-US-03 Vaccine and Methods for Prevention and Treatment of Drug-Resistance HIV-1 and Hepatitis B Virus US National Stage 11/816,704 9474793 Abandoned PDF
CC E-147-2008-0-PCT-02 Cyclized NGR Peptide Compounds, Compositions and Methods Of Their Use PCT PCT PCT/US2009/047328 Expired
NIAID E-070-2007-2-US-02 Human Cancer Therapy Using Engineered Matrix Metalloproteinase-Activated Anthrax Lethal Toxin That Target Tumor Vasculature US National Stage 12/519,362 Abandoned
NINDS E-214-2007-0-JP-06 An Implanted System For Sensing, Triggering And Automatically Controlling Swallowing To Maintain Control Of Secretions JP National Stage 2009-541475 Abandoned
NICHD E-247-2009-0-US-01 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes US 61/187,263 Abandoned
CC E-195-2008-0-IN-12 METHOD AND SYSTEM FOR PERFORMING BIOPSIES IN National Stage 299/CHENP/2011 Issued
CC E-195-2008-0-BR-05 System And Method For Prostate Cancer Detection And Distribution Mapping BR National Stage PI0909920-4 Issued
CC E-195-2008-0-JP-13 System And Method For Prostate Cancer Detection And Distribution Mapping JP National Stage 2011-514173 Issued
CC E-195-2008-0-RU-10 System And Method For Prostate Cancer Detection And Distribution Mapping RU National Stage 2011101930 Issued
CC E-195-2008-0-CN-04 System And Method For Prostate Cancer Detection And Distribution Mapping CN National Stage 200980123334.5 Issued
NCI E-014-2007-0-CN-05 SMOOTHENED POLYPEPTIDES AND METHODS OF USE CN National Stage 200780046085.5 Abandoned
CC E-195-2008-0-US-03 System And Method For Prostate Cancer Detection And Distribution Mapping US National Stage 12/993,854 8447384 Issued PDF
CC E-195-2008-0-EP-06 System for performing biopsies EP National Stage 09766260.5 Issued
CC E-195-2008-0-TR-11 System for performing biopsies TR EP 09766260.5 Issued
CC E-195-2008-0-DE-07 System for performing biopsies DE EP 09766260.5 Issued
CC E-195-2008-0-FR-09 System for performing biopsies FR EP 09766260.5 Issued
NIAID E-203-2008-0-PCT-02 T-Cell Enumeration Assay Using Dried Blood Spots For Diagnosis Of HIV Disease Stage PCT PCT PCT/US2009/003532 Expired
CC E-195-2008-0-PCT-02 System And Method For Prostate Cancer Detection And Distribution Mapping PCT PCT PCT/IB2009/052519 Expired
NIDDK E-235-2008-0-PCT-03 P2Y1 RECEPTOR ANTAGONISTS PCT PCT PCT/US2009/47204 Abandoned
NCI E-256-2006-0-CN-05 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs CN National Stage 200780045937.9 Abandoned
NIAID E-280-2001-0-AU-08 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) from cDNA AU DIV 2009202359 Abandoned
NIDCR E-300-2008-0-US-01 Identification Of DSG3 As A Biomarker For The Detection Of Metastasis In Lymph Nodes US 61/186,582 Abandoned
NCI E-209-2008-0-JP-07 Use of MIR-26 Family As Predictive Markers Of Hepatocellular Carcinoma And Responsiveness To Therapy JP National Stage 2011-513679 Abandoned
NCI E-209-2008-0-CN-05 Use of MIR-26 Family As Predictive Markers Of Hepatocellular Carcinoma And Responsiveness To Therapy CN National Stage 200980126520.4 Abandoned
NCI E-209-2008-0-AU-04 MicroRNAS As Predictors For Hepatocellular Carcinoma With Poor Outcomes And Responses To Interferon Therapy AU National Stage 2009257410 Abandoned
NCI E-209-2008-0-IT-15 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY IT EP 09763590.8 Abandoned
NCI E-209-2008-0-DE-09 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY DE EP 09763590.8 Abandoned
NCI E-209-2008-0-FR-13 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY FR EP 09763590.8 Abandoned
NCI E-209-2008-0-ES-10 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY ES EP 09763590.8 Abandoned
NCI E-209-2008-0-CH-12 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY CH EP 09763590.8 Abandoned
NCI E-209-2008-0-EP-06 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY EP National Stage 09763590.8 Abandoned